134 related articles for article (PubMed ID: 27489169)
1. Testosterone for Poor Ovarian Responders: Lessons From Ovarian Physiology.
Polyzos NP; Davis SR; Drakopoulos P; Humaidan P; De Geyter C; Vega AG; Martinez F; Evangelou E; van de Vijver A; Smitz J; Tournaye H; Barri P;
Reprod Sci; 2018 Jul; 25(7):980-982. PubMed ID: 27489169
[TBL] [Abstract][Full Text] [Related]
2. Testosterone for Poor Ovarian Responders: Lessons From Ovarian Physiology.
Polyzos NP; Davis SR; Drakopoulos P; Humaidan P; De Geyter C; Vega AG; Martinez F; Evangelou E; van de Vijver A; Smitz J; Tournaye H; Barri P;
Reprod Sci; 2018 Jul; 25(7):980-982. PubMed ID: 32720303
[TBL] [Abstract][Full Text] [Related]
3. Transdermal testosterone pretreatment in poor responders undergoing ICSI: a randomized clinical trial.
Bosdou JK; Venetis CA; Dafopoulos K; Zepiridis L; Chatzimeletiou K; Anifandis G; Mitsoli A; Makedos A; Messinis IE; Tarlatzis BC; Kolibianakis EM
Hum Reprod; 2016 May; 31(5):977-85. PubMed ID: 26956551
[TBL] [Abstract][Full Text] [Related]
4. The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis.
Bosdou JK; Venetis CA; Kolibianakis EM; Toulis KA; Goulis DG; Zepiridis L; Tarlatzis BC
Hum Reprod Update; 2012; 18(2):127-45. PubMed ID: 22307331
[TBL] [Abstract][Full Text] [Related]
5. Androgen supplementation in assisted reproduction: where are we in 2019?
Montoya-Botero P; Rodriguez-Purata J; Polyzos NP
Curr Opin Obstet Gynecol; 2019 Jun; 31(3):188-194. PubMed ID: 30855291
[TBL] [Abstract][Full Text] [Related]
6. Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique--a prospective, randomized, double-blind study.
Massin N; Cedrin-Durnerin I; Coussieu C; Galey-Fontaine J; Wolf JP; Hugues JN
Hum Reprod; 2006 May; 21(5):1204-11. PubMed ID: 16476678
[TBL] [Abstract][Full Text] [Related]
7. Androgens and diminished ovarian reserve: the long road from basic science to clinical implementation. A comprehensive and systematic review with meta-analysis.
Neves AR; Montoya-Botero P; Polyzos NP
Am J Obstet Gynecol; 2022 Sep; 227(3):401-413.e18. PubMed ID: 35364061
[TBL] [Abstract][Full Text] [Related]
8. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP
Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589
[TBL] [Abstract][Full Text] [Related]
9. A pharmacogenetic approach to improve low ovarian response: The role of CAG repeats length in the androgen receptor gene.
Lledo B; Llácer J; Ortiz JA; Martinez B; Morales R; Bernabeu R
Eur J Obstet Gynecol Reprod Biol; 2018 Aug; 227():41-45. PubMed ID: 29886316
[TBL] [Abstract][Full Text] [Related]
10. Transdermal testosterone may improve ovarian response to gonadotrophins in low-responder IVF patients: a randomized, clinical trial.
Fábregues F; Peñarrubia J; Creus M; Manau D; Casals G; Carmona F; Balasch J
Hum Reprod; 2009 Feb; 24(2):349-59. PubMed ID: 19054777
[TBL] [Abstract][Full Text] [Related]
11. The Role of Androgen Supplementation in Women With Diminished Ovarian Reserve: Time to Randomize, Not Meta-Analyze.
Neves AR; Montoya-Botero P; Polyzos NP
Front Endocrinol (Lausanne); 2021; 12():653857. PubMed ID: 34079524
[TBL] [Abstract][Full Text] [Related]
12. Association of basal serum androgen levels with ovarian response and ICSI cycle outcome.
Abide Yayla C; Ozkaya E; Kayatas Eser S; Sanverdi I; Devranoglu B; Kutlu T
Ir J Med Sci; 2018 May; 187(2):409-415. PubMed ID: 28744698
[TBL] [Abstract][Full Text] [Related]
13. Antral Follicle Priming Before Intracytoplasmic Sperm Injection in Previously Diagnosed Low Responders: A Randomized Controlled Trial (FOLLPRIM).
Escriva AM; Diaz-Garcia C; Monterde M; Rubio JM; Pellicer A
J Clin Endocrinol Metab; 2015 Jul; 100(7):2597-605. PubMed ID: 25955224
[TBL] [Abstract][Full Text] [Related]
14. The effect of transdermal testosterone gel pretreatment on controlled ovarian stimulation and IVF outcome in low responders.
Kim CH; Howles CM; Lee HA
Fertil Steril; 2011 Feb; 95(2):679-83. PubMed ID: 20801436
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of androgens and multivariate model for poor ovarian response.
Guo J; Zhang Q; Li Y; Huang J; Wang W; Huang L; Zhao X; Yang D
Reprod Biomed Online; 2014 Jun; 28(6):723-32. PubMed ID: 24745840
[TBL] [Abstract][Full Text] [Related]
16. Effects of long-term exogenous testosterone administration on ovarian morphology, determined by transvaginal (3D) ultrasound in female-to-male transsexuals.
Caanen MR; Schouten NE; Kuijper EAM; van Rijswijk J; van den Berg MH; van Dulmen-den Broeder E; Overbeek A; van Leeuwen FE; van Trotsenburg M; Lambalk CB
Hum Reprod; 2017 Jul; 32(7):1457-1464. PubMed ID: 28505246
[TBL] [Abstract][Full Text] [Related]
17. A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilization outcomes in poor responders.
Yeung TW; Chai J; Li RH; Lee VC; Ho PC; Ng EH
Fertil Steril; 2014 Jul; 102(1):108-115.e1. PubMed ID: 24796766
[TBL] [Abstract][Full Text] [Related]
18. Assessment of theca cell function: a prerequisite to androgen or luteinizing hormone supplementation in poor responders.
Hugues JN; Massart P; Cedrin-Durnerin I
Fertil Steril; 2013 Feb; 99(2):333-6. PubMed ID: 23058685
[TBL] [Abstract][Full Text] [Related]
19. 450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial.
Lefebvre J; Antaki R; Kadoch IJ; Dean NL; Sylvestre C; Bissonnette F; Benoit J; Ménard S; Lapensée L
Fertil Steril; 2015 Dec; 104(6):1419-25. PubMed ID: 26361207
[TBL] [Abstract][Full Text] [Related]
20. Androgen pretreatment in poor responders undergoing controlled ovarian stimulation and in vitro fertilization treatment.
Sunkara SK; Coomarasamy A
Fertil Steril; 2011 Jun; 95(8):e73-4; author reply e75. PubMed ID: 21601849
[No Abstract] [Full Text] [Related]
[Next] [New Search]
